Remove pharmaceutical-engineering topic production-systems
article thumbnail

Annex 1 in Force! Join the First Discussion after the 25 August Effective Date

ISPE

Gorton 21 September 2023 PIC/s Annex 1, and the WHO Annex 2 for the manufacturing of sterile products took effect on 25 August 2023, and the time to attend the 2023 ISPE Pharma 4.0™ As shown in the pictures, barrier systems such as RABS or Isolators, Material Airlock, E-Beam, and RTPs (Rapid Transfer Ports) are seen as technical solutions.

article thumbnail

ISPE Briefs: New Guide Explores Best Practices in Pharmaceutical Containment

ISPE

The ISPE Good Practice Guide: Containment for Potent Compounds covers all aspects of pharmaceutical containment, including background to safe working levels, mechanisms of exposure, and how exposure can be controlled. Containment (engineering controls) are amongst the preferable measure to be taken. Hoffmann-La Roche Ltd.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How Process Simulation Enhances Tech Transfer and Regulatory Submissions in the Biopharma Product Lifecycle

ISPE

Another important component is unstructured macroscopic kinetic models that capture cell culture performance including biomass growth, substrate consumption, and both growth and non-growth associated product formation, enabling the rate of change of different biomass states to be tracked. Register Now! 1 Harrison, Roger G.,

article thumbnail

Sonoma signs deal to set up manufacturing centre for cell therapies

Pharmaceutical Technology

The development and usage of innovative technologies, as well as expertise from the selection of cells and genetic modification to intelligent automation of production and information technology systems, will be part of the centre. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

article thumbnail

Discover, Delve, and Develop: Expert Workshops at the 2023 ISPE Annual Meeting & Expo

ISPE

™ Community of Practice (CoP) has been instrumental in the development and issuance of guidance on the use and implementation of computerized systems in the life sciences industry. Chief Digital Officers, Chief Technology Officers, and Quality, Engineering, Operations, and Manufacturing Leads are all highly encouraged to attend this workshop.

article thumbnail

Capsida Biotherapeutics and Prevail to develop CNS gene therapies

Pharmaceutical Technology

Capsida Biotherapeutics and Eli Lilly and Company ’s wholly owned subsidiary Prevail Therapeutics have announced a partnership for the development of non-invasive gene therapies for central nervous system (CNS) diseases. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Free Whitepaper.

article thumbnail

Kite and Daiichi Sankyo update cell therapy licensing agreement

Pharmaceutical Technology

The delivery of the product is anticipated to begin early next year. Directed against a cell membrane protein called CD19, Yescarta uses the immune system of the patient to destroy cancer. Directed against a cell membrane protein called CD19, Yescarta uses the immune system of the patient to destroy cancer. Free Whitepaper.